Brevan Howard Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.7K Sell
10,819
-44,566
-80% -$163K ﹤0.01% 2022
2026
Q1
$219K Buy
55,385
+36,800
+198% +$185K ﹤0.01% 1843
2025
Q4
$126K Buy
+18,585
New +$130K ﹤0.01% 1659
2024
Q2
– Sell
-127,349
Closed -$981K – 1268
2024
Q1
$981K Buy
127,349
+68,883
+118% +$554K 0.01% 278
2023
Q4
$513K Buy
+58,466
New +$428K 0.01% 469

Other funds holding MDXG

Brevan Howard Capital Management's MDXG Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its MiMedx Group (MDXG) stake by 80% in Q2 2026, selling an estimated $163K and leaving 10,819 shares worth $41.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Brevan Howard Capital Management first reported a position in MDXG in Q4 2023 and has held it in 5 quarters since. The position peaked at $981K in Q1 2024. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Brevan Howard Capital Management held 10,819 shares of MiMedx Group worth $41.7K as of Q2 2026.
  • Brevan Howard Capital Management sold 44,566 MiMedx Group shares in Q2 2026, an estimated $163K.
  • MiMedx Group made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #2022 holding.
  • Brevan Howard Capital Management first reported a position in MiMedx Group in Q4 2023 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's MiMedx Group position peaked at $981K in Q1 2024.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.